Clinical Trial Update: Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Effects of Multiple Rising Subcutaneous Doses of BI 655064 in Healthy Volunteers and in Rheumatoid Arthritis Patients With Prior Inadequate Response to Methotrexate Therapy [Phase 1]

View source ↗

Summary

Phase 1 trial assessing safety, tolerability, pharmacokinetics, pharmacodynamics, and clinical effects of multiple rising subcutaneous doses of BI 655064 in hea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• BI 655064

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Arthritis, Rheumatoid, Healthy | Phase 1 | Status: COMPLETED | Results posted: 2024-03-21